Galectin Therapeutics Inc. (GALT) vs High Tide Inc. (HITI)

A side-by-side comparison of Galectin Therapeutics Inc. and High Tide Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Galectin Therapeutics Inc. logo
GALT
Galectin Therapeutics Inc.
$242M
$3.68HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
High Tide Inc. logo
HITI
High Tide Inc.
$238M
$2.71HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT

Total return — GALT vs HITI

growth of $100 · dividends reinvested · last 8y
GALT -19.4% (-2.7%/yr)HITI -32.8% (-4.9%/yr)GALT compounded faster over this window
0100200300Start $100202120232025$81$67
GALT HITI

GALT vs HITI: by the numbers

  • •GALT is the larger company ($242M vs $238M market cap).
  • •Both run net losses; GALT's is the smaller (0.00% vs -4.52% net margin).

Metrics side by side

Valuation

MetricGALTHITI
P/S ratioN/A0.45
P/B ratioN/A3.17
EV / EBITDAN/A12.82
FCF yieldN/A4.83%

Profitability

MetricGALTHITI
Gross margin0.00%25.85%
Operating margin0.00%0.56%
Net margin0.00%-4.52%
ROEN/A-31.55%
ROIC-1718.59%1.38%

Growth (annualized)

MetricGALTHITI
Revenue CAGR (5Y)N/A33.84%
Total return CAGR (5Y)0.60%-14.29%

Frequently asked

How have GALT and HITI total returns compared?
Over the past 5 years, GALT delivered 0.60% and HITI delivered -14.29% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GALT analysisFull HITI analysisInteractive comparison tool

Dig into the metrics

Galectin Therapeutics ROEHigh Tide ROEGalectin Therapeutics operating marginHigh Tide operating marginGalectin Therapeutics revenue growthHigh Tide revenue growthGalectin Therapeutics free cash flowHigh Tide free cash flow

Galectin Therapeutics & High Tide appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.